SCHEMBL17003768

SCHEMBL17003768

FC(F)Oc1ccc(-c2cc[nH]n2)cc1OC1CCCC1

nearest known ligand 0.50

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PDE4D Q08499 15/20 0.50
PDE4B Q07343 12/20 0.47
PDE4A P27815 12/20 0.46
PDE4C Q08493 10/20 0.46
PDE3B Q13370 2/20 0.45
PDE3A Q14432 2/20 0.45
LMNA P02545 1/20 0.45
TP53 P04637 1/20 0.45
CYP1A2 P05177 1/20 0.45
CYP2C9 P11712 1/20 0.45
HPGD P15428 1/20 0.45
TSHR P16473 1/20 0.45
MAPK1 P28482 1/20 0.45
CYP2C19 P33261 1/20 0.45
BLM P54132 1/20 0.45
PMP22 Q01453 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3605697 0.85 PDE4D (0.55) PDE4DPDE4BPDE4APDE4CPDE3B
SCHEMBL3616202 0.84 PDE4A (0.59) PDE4DPDE4BPDE4APDE4C
SCHEMBL3606207 0.83 PDE4D (0.42) PDE4DPDE4BPDE4APDE4CPDE3B
SCHEMBL8635918 0.83 PDE4D (0.69) PDE4DPDE4BPDE4APDE4CPDE3B
SCHEMBL8633365 0.82 PDE4D (0.67) PDE4DPDE4BPDE4APDE4CPDE3B
SCHEMBL9269661 0.78 PDE4D (0.46) PDE4DPDE4BPDE4APDE4CPDE3B
SCHEMBL9181365 0.78 PDE4D (0.59) PDE4DPDE4BPDE4APDE4CPDE3B
SCHEMBL17011762 0.78 PDE4D (0.58) PDE4DPDE4BPDE4APDE4C
SCHEMBL18288862 0.77 FPR2 (0.37) PDE4DPDE4BPDE4APDE4C
SCHEMBL28052513 0.76 SMN1; SMN2 (0.46) PDE4DPDE4BPDE4APDE4CPDE3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3105206-B1 MORPHOLINE DERIVATIVES HAVING A SELECTIVE PDE4D INHIBITING ACTIVITY UNIV DEGLI STUDI GENOVA (IT) 2019-08-07 EP disclosed
EP-3105206-B1 MORPHOLINE DERIVATIVES HAVING A SELECTIVE PDE4D INHIBITING ACTIVITY UNIV DEGLI STUDI GENOVA (IT) 2019-08-07 EP disclosed
US-10017480-B2 Compounds having a selective PDE4D inhibiting activity UNIVERSITA DEGLI STUDI DI GENOVA (IT) 2018-07-10 US disclosed
US-10017480-B2 Compounds having a selective PDE4D inhibiting activity UNIVERSITA DEGLI STUDI DI GENOVA (IT) 2018-07-10 US disclosed
US-10017480-B2 Compounds having a selective PDE4D inhibiting activity UNIVERSITA DEGLI STUDI DI GENOVA (IT) 2018-07-10 US disclosed
EP-3105206-A1 NEW COMPOUNDS HAVING A SELECTIVE PDE4D INHIBITING ACTIVITY Universita' degli Studi di Genova (IT) 2016-12-21 EP disclosed
US-20160355489-A1 NEW COMPOUNDS HAVING A SELECTIVE PDE4D INHIBITING ACTIVITY THE TRUSTEES OF COLUMBIA UNIVERSITY 2016-12-08 US disclosed
US-20160355489-A1 NEW COMPOUNDS HAVING A SELECTIVE PDE4D INHIBITING ACTIVITY THE TRUSTEES OF COLUMBIA UNIVERSITY 2016-12-08 US disclosed
US-20160355489-A1 NEW COMPOUNDS HAVING A SELECTIVE PDE4D INHIBITING ACTIVITY THE TRUSTEES OF COLUMBIA UNIVERSITY 2016-12-08 US disclosed
WO-2015121212-A1 NEW COMPOUNDS HAVING A SELECTIVE PDE4D INHIBITING ACTIVITY UNIVERSITÀ DEGLI STUDI DI GENOVA (IT) 2015-08-20 WO disclosed
WO-2015121212-A1 NEW COMPOUNDS HAVING A SELECTIVE PDE4D INHIBITING ACTIVITY UNIVERSITÀ DEGLI STUDI DI GENOVA (IT) 2015-08-20 WO disclosed
EP-2907806-A1 New compounds as selective PDE4D inhibitors UNIVERSITA DEGLI STUDI DI GENOVA (IT) 2015-08-19 EP disclosed
EP-2907806-A1 New compounds as selective PDE4D inhibitors UNIVERSITA DEGLI STUDI DI GENOVA (IT) 2015-08-19 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160355489-A1 NEW COMPOUNDS HAVING A SELECTIVE PDE4D INHIBITING ACTIVITY PDE4A, PDE4D, PDE4B PDE4D 2/4885PDE4B 3/4885PDE4A 1/4885
US-10017480-B2 Compounds having a selective PDE4D inhibiting activity PDE4A, PDE4D, PDE2A PDE4D 2/4885PDE4B 4/4885PDE4A 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.